Sydney, New South Wales, Australia In 2009 was created Moelis Australia Asset Management, which is appeared as Corporate Investor. The leading representative office of defined Corporate Investor is situated in the Sydney. The venture was found in Australia.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Moelis Australia Asset Management, startups are often financed by Carthona Capital, Yellow Brick Capital Advisers, Singapore Press Holdings. The meaningful sponsors for the fund in investment in the same round are Square Peg Capital, Uniseed Ventures, Time Inc.. In the next rounds fund is usually obtained by Tempus Partners, Roger Allen, Regal Funds Management.
The typical startup value when the investment from Moelis Australia Asset Management is 100-500 millions dollars. Opposing the other organizations, this Moelis Australia Asset Management works on 0 percentage points less the average amount of lead investments. Speaking about the real fund results, this Corporate Investor is 37 percentage points more often commits exit comparing to other organizations. The fund is constantly included in 2-6 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2018. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity.
Among the most successful fund investment fields, there are Data Integration, Education. Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund. Among the various public portfolio startups of the fund, we may underline Sparesbox, Ansarada, Clinical Genomics Technologies The fund has no exact preference in some founders of portfolio startups. In case when startup counts 3 or 5+ of the founder, the chance for it to get the investment is meager. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Australia.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Betatron Venture Group | China, Hong Kong, Hong Kong Island |
| Heritage Bank of Commerce | California, San Jose, United States |
| Huajian Touzi | Beijing, Beijing, China |
| Junyang Capital | - |
| KAHM Capital | - |
| Mr. Youth | New York, New York, United States |
| National Biofilms Innovation Centre | England, London, United Kingdom |
| National Eye Institute | Bethesda, Maryland, United States |
| New World Strategic Investment | China, Shanghai |
| NextView Ventures | Boston, Massachusetts, United States |
| Orient Securities Capital Investment | China, Shanghai |
| Ortho Vision | - |
| Polymath Network | Barbados, Haggatt Hall, Saint George |
| Rho Capital Partners | New York, New York, United States |
| SENS Foundation | California, Mountain View, United States |
| Shenzhen Tianyi Capital Venture Capital Management | China, Guangdong, Shenzhen |
| Starfield Food & Science Technology | China, Guangdong, Shenzhen |
| Tudor Investments | Connecticut, Greenwich, United States |
| Zhijin Capital | China, Guangdong, Shenzhen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Spectainer | $5M | 15 Jul 2022 | Phillip, Australian Capital Territory, Australia | ||
Pendula | $4M | 02 Aug 2021 | Sydney, New South Wales, Australia | ||
Liquid Instruments | $13M | 19 May 2021 | Canberra, Australia | ||
Comestri | $10M | 10 May 2021 | Epping, New South Wales, Australia | ||
CitrusAd | $5M | 29 Mar 2020 | Brisbane City, Queensland, Australia | ||
Clinical Genomics Technologies | 01 Jun 2018 | Sydney, New South Wales, Australia | |||
| 31 Oct 2017 | Canberra, Australia | ||||
ROKT | $26M | 12 Jun 2017 | New York, New York, United States | ||
Smart Sparrow | $4M | 11 Apr 2017 | New South Wales |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Spectainer | $5M | 15 Jul 2022 | Phillip, Australian Capital Territory, Australia | ||
Pendula | $4M | 02 Aug 2021 | Sydney, New South Wales, Australia | ||
Liquid Instruments | $13M | 19 May 2021 | Canberra, Australia | ||
Comestri | $10M | 10 May 2021 | Epping, New South Wales, Australia | ||
CitrusAd | $5M | 29 Mar 2020 | Brisbane City, Queensland, Australia | ||
Clinical Genomics Technologies | 01 Jun 2018 | Sydney, New South Wales, Australia | |||
| 31 Oct 2017 | Canberra, Australia | ||||
ROKT | $26M | 12 Jun 2017 | New York, New York, United States | ||
Smart Sparrow | $4M | 11 Apr 2017 | New South Wales |
